ResearcherUtrecht UniversityActive in the last 2 years
Jacobien C.M. Scheepens
Matched on OpenAlex author ID A5106903174. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 51
2025: 2 papers · 2026: 4 papers
Papers 6
- The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Co-author DOI 10.1002/gin2.70074↗
- The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analy… Co-author DOI 10.1016/j.ejca.2026.116822↗
- Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study. Co-author DOI 10.1093/bjs/znag075↗
- Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An International Multicenter Cohort Study on S… Co-author DOI 10.1097/sla.0000000000006638↗
- Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotactic Magnetic Resonance Guided Radiation Th… First author DOI 10.1016/j.ijrobp.2025.03.046↗
- Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. Co-author DOI 10.1186/s12885-025-13554-w↗
Closest collaborators
The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lois A. Daamen · 2 shared papers, 2025–2026 · strength 0.40
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822↗
- Paper Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotacti… DOI 10.1016/j.ijrobp.2025.03.046↗
- Gert J. Meijer · 2 shared papers, 2025–2026 · strength 0.40
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822↗
- Paper Quality of Life and Toxicity in Patients With Pancreatic Ductal Adenocarcinoma Treated With Online Adaptive Stereotacti… DOI 10.1016/j.ijrobp.2025.03.046↗
- Izaak Quintus Molenaar · 2 shared papers, 2026 · strength 0.40
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Hjalmar C. van Santvoort · 2 shared papers, 2026 · strength 0.40
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- Marc G. Besselink · 2 shared papers, 2026 · strength 0.40
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822↗
- Paper Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An Int… DOI 10.1097/sla.0000000000006638↗
- L.C. Leeuwenburgh · 1 shared paper, 2026 · strength 0.21
- Robert C. Verdonk · 1 shared paper, 2026 · strength 0.21
- Hanne D. Heerkens · 1 shared paper, 2026 · strength 0.21
- Pauline A. J. Vissers · 1 shared paper, 2026 · strength 0.21
- Johanna W. Wilmink · 1 shared paper, 2026 · strength 0.21
- Guus Grimbergen · 1 shared paper, 2026 · strength 0.21
- Jeanin Elise van Hooft · 1 shared paper, 2026 · strength 0.21
- Peter G. Noordzij · 1 shared paper, 2026 · strength 0.21
- Anna M E Bruynzeel · 1 shared paper, 2026 · strength 0.21
- Vincent Erwin de Meijer · 1 shared paper, 2026 · strength 0.21
- Hanneke W.M. van Laarhoven · 1 shared paper, 2026 · strength 0.21
- Lydia G. van der Geest · 1 shared paper, 2026 · strength 0.21
- Judith de Vos‐Geelen · 1 shared paper, 2026 · strength 0.21
- Ignace H. J. T. de Hingh · 1 shared paper, 2026 · strength 0.21
- Bert A. Bonsing · 1 shared paper, 2026 · strength 0.21
- Martijn W.J. Stommel · 1 shared paper, 2026 · strength 0.21
- Marjolein Y.V. Homs · 1 shared paper, 2026 · strength 0.21
- William Adrian Hall · 1 shared paper, 2025 · strength 0.20
- Jasmijn Maria Westerhoff · 1 shared paper, 2025 · strength 0.20
- Uffe Bernchou · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.